The Industrial Pharmaceutical Laboratory (LIF) of the province of Santa Fe will begin to supply the “Dr. Orlando Alassia” Children’s Hospital with Trihexyphenidyl Hydrochloride 5mg, a medicine that is no longer produced in private laboratories in the country and is used in the hospital to treat neurological patients.
The LIF has the mission of producing medicines to supply primary health care, guaranteeing access to free, safe and effective medicines to the people of Santa Fe who go to the provincial Public Health System. In turn, the LIF meets the needs of the so-called “orphan drugs”, which are those that, being of high therapeutic interest and scientifically viable, are not available due to different circumstances.
In the case of Trihexyphenidyl Hydrochloride 5mg, it is a medicine that was produced until some time ago in two private laboratories in the country, which discontinued their production. This is where the LIF has a fundamental role in guaranteeing access to health, understanding medicine as a social good and not as a commercial good.
In this sense, the head of the Alassia Pharmacy, Diego Galliari, reported that “Trihexyphenidyl is a medicine that we use to treat neurological patients and that we bought from the private industry until 2021, when the two laboratories that produced it They discontinued their production. Given this situation, as we had many patients to treat, we had no other alternative than to prepare them in the hospital laboratory as a master formula. However, as the demand grew, we went to the LIF with the need we had to try to find a solution”.
